Loading...

PE anti-mouse CD11c Antibody PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg DKK428
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg DKK1088
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  4. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  5. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  6. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  7. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  8. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  9. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  10. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  11. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  12. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  13. Guo R, et al. 2022. Cells. 12: . PubMed
  14. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  15. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  16. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  17. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  18. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  19. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  20. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  21. Boroumand P, et al. 2022. Elife. 11:. PubMed
  22. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  23. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  24. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  25. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  26. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  27. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  28. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  29. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  30. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  31. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  32. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  33. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  34. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  35. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  36. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  37. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  38. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  39. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  40. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  41. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  42. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  43. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  44. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  45. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  46. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  47. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  49. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  53. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  54. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  55. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  56. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  57. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  58. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  59. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  60. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  63. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  64. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  65. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  66. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  67. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  74. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  75. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  76. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  77. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  78. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  79. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  80. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  81. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  82. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  83. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  84. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  85. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  86. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  87. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  88. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  89. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  90. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  91. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  92. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  93. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  94. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  95. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  96. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  97. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  98. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  99. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  100. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  101. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  102. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  103. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  104. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  105. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  106. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  107. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  108. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  109. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  110. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  111. De Simone G, et al. 2021. Immunity. :. PubMed
  112. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  113. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  114. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  115. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  116. Vorselen D, et al. 2021. Elife. 10:. PubMed
  117. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  119. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  120. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  121. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  122. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  123. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  124. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  125. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  126. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  127. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  128. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  129. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  130. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  131. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  132. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  133. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  134. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  135. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  136. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  137. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  138. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  139. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  140. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  141. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  142. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  143. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  144. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  145. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  146. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  147. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  148. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  151. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  152. Gu H, et al. 2021. Elife. 10:. PubMed
  153. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  154. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  155. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  156. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  157. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  158. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  159. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  160. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  161. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  162. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  163. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  164. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  165. Bussey KA, et al. 2019. J Virol. 93. PubMed
  166. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  167. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  168. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  169. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  170. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  173. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  174. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  175. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  176. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  177. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  178. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  179. Jones GS, et al. 2020. mSphere. 5:. PubMed
  180. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  181. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  182. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  183. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  184. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  185. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  186. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  187. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  188. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  189. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  190. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  191. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  193. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  194. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  195. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  196. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  197. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  198. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  199. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  200. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  201. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  202. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  203. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  204. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  205. Guo R, et al. 2022. Cells. 12: . PubMed
  206. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  207. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  208. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  209. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  210. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  211. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  212. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  213. Boroumand P, et al. 2022. Elife. 11:. PubMed
  214. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  215. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  216. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  217. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  218. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  219. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  220. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  221. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  222. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  223. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  224. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  225. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  226. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  227. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  228. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  229. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  230. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  231. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  232. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  233. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  234. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  235. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  236. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  237. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  238. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  239. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  240. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  241. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  245. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  246. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  247. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  248. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  249. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  250. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  251. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  252. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  253. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  254. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  255. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  256. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  257. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  258. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  259. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  260. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  261. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  262. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  263. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  264. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  265. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  266. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  267. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  268. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  269. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  270. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  271. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  272. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  273. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  274. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  275. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  276. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  277. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  278. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  279. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  280. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  281. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  282. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  283. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  284. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  285. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  286. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  287. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  288. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  289. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  290. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  291. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  292. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  293. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  294. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  295. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  296. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  297. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  298. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  299. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  300. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  301. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  302. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  303. De Simone G, et al. 2021. Immunity. :. PubMed
  304. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  305. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  306. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  307. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  308. Vorselen D, et al. 2021. Elife. 10:. PubMed
  309. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  310. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  311. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  312. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  313. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  314. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  315. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  316. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  317. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  318. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  319. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  320. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  321. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  322. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  323. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  324. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  325. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  326. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  327. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  328. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  329. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  330. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  331. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  332. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  333. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  334. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  335. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  336. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  337. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  338. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  339. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  340. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  341. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  342. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  343. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  344. Gu H, et al. 2021. Elife. 10:. PubMed
  345. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  346. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  347. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  348. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  349. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  350. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  351. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  352. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  353. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  354. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  355. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  356. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  357. Bussey KA, et al. 2019. J Virol. 93. PubMed
  358. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  359. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  360. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  361. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  362. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  363. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  364. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  365. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  366. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  367. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  368. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  369. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  370. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  371. Jones GS, et al. 2020. mSphere. 5:. PubMed
  372. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  373. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  374. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  375. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  376. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  377. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  378. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  379. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  380. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  381. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  382. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  383. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  384. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg DKK428
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg DKK1088
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  4. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  5. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  6. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  7. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  8. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  9. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  10. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  11. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  12. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  13. Guo R, et al. 2022. Cells. 12: . PubMed
  14. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  15. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  16. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  17. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  18. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  19. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  20. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  21. Boroumand P, et al. 2022. Elife. 11:. PubMed
  22. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  23. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  24. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  25. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  26. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  27. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  28. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  29. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  30. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  31. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  32. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  33. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  34. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  35. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  36. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  37. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  38. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  39. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  40. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  41. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  42. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  43. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  44. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  45. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  46. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  47. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  48. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  49. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  53. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  54. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  55. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  56. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  57. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  58. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  59. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  60. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  63. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  64. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  65. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  66. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  67. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  74. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  75. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  76. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  77. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  78. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  79. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  80. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  81. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  82. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  83. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  84. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  85. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  86. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  87. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  88. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  89. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  90. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  91. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  92. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  93. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  94. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  95. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  96. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  97. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  98. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  99. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  100. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  101. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  102. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  103. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  104. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  105. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  106. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  107. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  108. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  109. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  110. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  111. De Simone G, et al. 2021. Immunity. :. PubMed
  112. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  113. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  114. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  115. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  116. Vorselen D, et al. 2021. Elife. 10:. PubMed
  117. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  119. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  120. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  121. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  122. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  123. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  124. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  125. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  126. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  127. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  128. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  129. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  130. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  131. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  132. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  133. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  134. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  135. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  136. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  137. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  138. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  139. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  140. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  141. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  142. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  143. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  144. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  145. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  146. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  147. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  148. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  151. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  152. Gu H, et al. 2021. Elife. 10:. PubMed
  153. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  154. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  155. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  156. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  157. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  158. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  159. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  160. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  161. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  162. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  163. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  164. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  165. Bussey KA, et al. 2019. J Virol. 93. PubMed
  166. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  167. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  168. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  169. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  170. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  171. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  172. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  173. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  174. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  175. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  176. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  177. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  178. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  179. Jones GS, et al. 2020. mSphere. 5:. PubMed
  180. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  181. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  182. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  183. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  184. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  185. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  186. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  187. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  188. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  189. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  190. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  191. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  193. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  194. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  195. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  196. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  197. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  198. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  199. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  200. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  201. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  202. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  203. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  204. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  205. Guo R, et al. 2022. Cells. 12: . PubMed
  206. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  207. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  208. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  209. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  210. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  211. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  212. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  213. Boroumand P, et al. 2022. Elife. 11:. PubMed
  214. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  215. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  216. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  217. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  218. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  219. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  220. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  221. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  222. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  223. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  224. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  225. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  226. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  227. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  228. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  229. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  230. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  231. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  232. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  233. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  234. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  235. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  236. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  237. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  238. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  239. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  240. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  241. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  245. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  246. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  247. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  248. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  249. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  250. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  251. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  252. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  253. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  254. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  255. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  256. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  257. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  258. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  259. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  260. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  261. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  262. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  263. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  264. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  265. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  266. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  267. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  268. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  269. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  270. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  271. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  272. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  273. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  274. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  275. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  276. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  277. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  278. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  279. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  280. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  281. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  282. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  283. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  284. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  285. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  286. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  287. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  288. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  289. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  290. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  291. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  292. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  293. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  294. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  295. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  296. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  297. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  298. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  299. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  300. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  301. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  302. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  303. De Simone G, et al. 2021. Immunity. :. PubMed
  304. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  305. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  306. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  307. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  308. Vorselen D, et al. 2021. Elife. 10:. PubMed
  309. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  310. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  311. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  312. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  313. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  314. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  315. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  316. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  317. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  318. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  319. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  320. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  321. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  322. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  323. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  324. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  325. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  326. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  327. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  328. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  329. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  330. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  331. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  332. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  333. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  334. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  335. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  336. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  337. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  338. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  339. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  340. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  341. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  342. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  343. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  344. Gu H, et al. 2021. Elife. 10:. PubMed
  345. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  346. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  347. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  348. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  349. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  350. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  351. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  352. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  353. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  354. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  355. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  356. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  357. Bussey KA, et al. 2019. J Virol. 93. PubMed
  358. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  359. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  360. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  361. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  362. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  363. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  364. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  365. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  366. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  367. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  368. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  369. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  370. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  371. Jones GS, et al. 2020. mSphere. 5:. PubMed
  372. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  373. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  374. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  375. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  376. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  377. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  378. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  379. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  380. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  381. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  382. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  383. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  384. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account